what is known already: DNMT1 maintains the methylation profile of genes during cell division. The methylation status of genes involved in placenta development is altered in embryos obtained in vitro. Disturbances in the epigenetic regulation of gene expression during placentogenesis could be involved in the frequent developmental arrest and loss of IVP embryos. study design, size, duration: Forty sheep were naturally mated (Group 1, CTR). IVP blastocysts (2-4 per ewe) were surgically transferred to the remaining 46 recipient sheep 6 days after oestrus (Group 2). Twenty-one recipients from Group 1 and 27 recipients from Group 2 were allowed to deliver in order to compare embryo survival in both groups at term (150 days). From the remaining recipients (n ¼ 38), fetuses and placentae of both groups were recovered by paramedian laparotomy at Days 20, 22, 24, 26 and 28 of gestation. materials, setting, methods: Immediately after collection, early placental tissues (chorion-allantois) were snap frozen in liquid nitrogen and DNMT1 expression and activity was evaluated. mRNA levels (for DNMT1, HDAC2, PCNA, DMAP1, MEST, IGF2, CDKN1C, H19) and the methylation status of H19 were also analyzed. Furthermore, embryo size and survival rate were measured. main results and the role of chance: Our study shows that DNMT1 expression was reduced in early placentae from sheep IVP embryos. This reduction was associated with growth arrest and subsequent death of the sheep embryos. Conversely, normal levels of DNMT1 and its cofactors were observed in placentae from IVP embryos that survived this developmental bottleneck. Although DNA methylation machinery was severely compromised in IVP placentae only up to Day 24, the low DNMT1 enzymatic activity that persisted after this stage in IVP placentae was not lethal for the developing embryos.
Introduction
Placental development requires a coordinated series of epigenetic modifications to regulate the expression of genes at key stages. Growing evidence suggests that disruption of placental development during the initial pregnancy phases is involved in the developmental failure of embryos from different species, including humans (Meegdes et al., 1988) , as well as in the aetiology of several pregnancy disorders, such as pre-eclampsia and intrauterine growth restriction (Maccani and Marsit, 2009 ) and especially the abnormal phenotypes of pregnancies obtained by assisted reproduction technologies (ART) (Wang et al., 2004; Miles et al., 2005; Farin et al., 2006; Healy et al., 2010) . Little is known about the mechanisms contributing to altered placentation in ART embryos. It is commonly thought that in vitro culture may influence the regulation of imprinted genes (Khosla et al., 2001; Mann et al., 2004; Fowden et al., 2006) . However, epigenetic defects in placentae of ART embryos are not limited to imprinted genes (Katari et al., 2009; Fauque et al., 2010) , suggesting that the genes responsible for placenta development are regulated by common upstream functions, independently of genomic imprinting. Indeed, several lines of evidence suggest that the methylation and expression status of genes (imprinted and not) involved in placental development is altered in these pregnancies (Constancia et al., 2004; Horsthemke and Ludwig 2005; Katari et al., 2009; Turan et al., 2010; Zhang et al., 2010) . During cell division, the methylation profile of genes is maintained by DNA methyltransferase 1 (DNMT1). The inactivation of the Dnmt1 gene in the mouse leads to global loss of methylation, biallelic expression or silencing of imprinted genes (Li et al., 1992; Caspary et al., 1998) and embryo lethality at 9.5 days post coitum (dpc) (Li et al., 1992) . DNA methylation requires the co-ordinated interaction of different factors: DMAP1 forms a complex with DNMT1 and HDAC2, regulating transcription and chromatin modification (Rountree et al., 2000) . Correct localization of DNMT1 and preference for hemi-methylated DNA is mediated by PCNA (Chuang et al., 1997) and UHRF1 (Bostick et al., 2007) , respectively. Given the apparent involvement of DNMT1 in epigenetic regulation of fetal development in mouse (Li et al., 1992; Howell et al., 2001) we asked whether the deregulation of the DNMT1 gene might be involved in the placentation defect often encountered in in vitro produced (IVP) embryos. To this aim, we focused our investigation on placentae obtained from IVP sheep embryos, because sheep have been suggested to be the best model for studying human pregnancy (Barry and Anthony, 2008a,b) . We thus assessed the functionality of the DNMT1 machinery in developing (20 -28 days of pregnancy) and term placentae (150 days of gestation) of IVP sheep embryos and in control embryos obtained by natural mating. The results demonstrate that DNMT1 is down-regulated in IVP placentae and that this defect is associated with embryonic growth arrest and death at Day 24 of pregnancy.
Materials and Methods
All chemicals, unless otherwise indicated, were obtained from Sigma Chemicals Co. (St. Louis, MO, USA).
In vitro production of embryos
All animal experiments were performed in accordance with the DPR 27/ 1/1992 (Italian Animal Protection Regulations) and in conformity with the European Community regulations 86/609. Methods for in vitro embryo production were adapted from those previously described (Ptak et al., 2002) . Briefly, sheep ovaries were collected from local slaughterhouses. Oocytes were aspirated with 21-G needles and matured in bicarbonatebuffered TCM-199 containing 2 mM glutamine, 0.3 mM sodium pyruvate, 100 mM cysteamine, 10% fetal bovine serum (Gibco), 5 mg/ml FSH (Ovagen, ICP, Auckland, New Zealand), 5 mg/ml LH and 1 mg/ml oestradiol in a humidified atmosphere of 5% CO 2 in air at 38.58C for 24 h. Matured oocytes were partially denuded and transferred into 50 ml drops of bicarbonate-buffered synthetic oviductal fluid (SOF) enriched with 2% (v:v) heat-inactivated oestrous sheep serum, 2.9 mM calcium lactate and 16 mM isoproterenol. Ram semen was thawed and washed in SOF at 200 g for 5 min. Fertilization was carried out at a final concentration of 5 × 10 6 sperm/ml. After 18 h, presumptive zygotes were transferred into 20 ml drops of SOF enriched with 1% (v:v) minimum essential medium non-essential amino acids (Gibco), 1% (v:v) basal medium Eagles essential amino acids, 2 mM glutamine and 8 mg/ml bovine serum albumin (BSA) and covered with mineral oil (pre-washed in SOF). Cultures were carried out in a humidified atmosphere of 5% CO 2 , 7% O 2 and 88% N 2 at 38.58C. On Days 3 and 5 of culture (Day 0 ¼ day of fertilization) the medium was replaced.
Animal treatment and sample recovery
Eighty-six Sardinian sheep were synchronized with Crono-gests sponges of 25 mg (Intervet, Milan, Italy) . Forty sheep were naturally mated (Group 1, CTR). IVP blastocysts (2-4 per ewe) were surgically transferred to the remaining 46 recipient sheep 6 days after oestrus (Group 2). Twenty-one recipients from Group 1 and 27 recipients from Group 2 were allowed to deliver in order to compare embryo survival in both groups at term (150 days DNA methyltransferase activity assay DNA methyltransferase activity was measured using the EpiQuik DNA Methyltransferase Activity/Inhibition Screening Assay Kit (Epigentek, Brooklyn, NY, USA) according to the manufacturer's instructions.
Immunoblotting
Protein extracts were denatured by heating at 958C for 5 min in 20% (v:v) glycerol in 50 mM Tris -HCl at pH 6.8. Samples were subjected to electrophoresis in 4 -12% gradient SDS polyacrylamide precast gels (Invitrogen, Milan, Italy). After electrophoresis proteins were transferred to nitrocellulose membranes using an iBlot TM Gel Transfer System (Invitrogen, Milan, Italy). Membranes were blocked in TBS-T (0.2% (v:v) Tween-20 in 20 mM Tris, 137 mM NaCl at pH 7.6) with 5% (w:v) skimmed milk, and then washed three times in TBS-T at room temperature. Membranes were incubated with the primary antibodies anti-DNMT1 (1:300; SC-10222; Santa Cruz Biotechnology, Santa Cruz, USA) and anti-b-Actin as the loading control (1:1000; SC-1615, Santa Cruz Biotechnology, Santa Cruz, USA) diluted in blocking solution at 48C overnight. After three washes with TBS-T, membranes were incubated at room temperature with the secondary antibody (anti-goat IgG HRP-labelled, Santa Cruz Biotechnology) diluted 1:1000 in blocking solution for 1 h. After three washes in TBS-T, the final detection was performed by enhanced chemiluminescence using the ECL Plus Western Blotting Detection System (AmershamPharmacia, Piscataway, USA). Image acquisition was carried out using the ChemiDoc System (Bio-Rad, Milan, Italy).
ELISA assay
The DNMT1 protein concentration in chorion-allantois was assayed using the Epiquik DNMT1 Assay Kit (Epigentek, Brooklyn, NY, USA) according to the manufacturer's protocol.
Gene expression analysis
Gene expression was assessed by measuring mRNA levels for specific genes. Total RNA was extracted from placentae of control and IVP embryos using the RNeasy Mini Kit (Qiagen, Milan, Italy) according to the manufacturer's instructions. Then, 1 mg of total RNA was reverse transcribed to first-strand cDNA using the QuantiTect Reverse Transcription Kit (Qiagen) following the manufacturer's recommended protocol. Control reactions, omitting reverse transcriptase or RNA, were included. The cDNAs obtained from placental tissues were used for gene expression analysis using specific primers designed to anneal at 588C: HDAC2 (histone deacetylase 2) (NM_001075146): FW 5 ′ -aacctcataggatccgc atgacc-3 ′ ; RV 5 ′ -aactgagccaccagttgaaagc-3 ′ ; UHRF1 (ubiquitin-like, containing PHD and RING finger domain 1) (NM_001103098): FW 5
′ . PCR reactions were performed using Platinum SYBR Green qPCR SuperMix UDG with ROX (Invitrogen, Milan, Italy) with an ABI PRISM 7900 Real-time PCR System (Applied Biosystems, Carlsbad, USA), according to the manufacturer's instructions. To avoid false-positive signals, dissociation-curve analyses were performed at the end of each run. Relative gene expression data were calculated using the comparative threshold cycle method (2DDCt) with ß-ACTIN (NM_001009784) as endogenous control (FW: 5 ′ -aatcgtccgtgacatcaag-3 ′ ; RW: 5 ′ -ttcatgatggaattgaagg-3 ′ ).
Methylation analysis
For genomic DNA extraction chorion-allantoid tissues obtained from IVP and CTR fetuses were homogenized in the HIRT buffer containing 200 mg/ml of Proteinase K and digested overnight at 558C. RNA was digested at 378C for 1 h with RNAse A 10 mg/ml. DNA was phenol-chloroform-isoamil alcohol (25:24:1) extracted. Ethanolprecipitated DNA was resuspended in 100 ml of molecular biology grade water at 658C. DNA was bisulphite modified with MethylDetector Kit (Active Motif, Carlsbad, USA) according to the manufacturer's instructions. Forty nanograms of modified DNA was MS-PCR amplified using PCR Master Mix (Promega, Wisconsin, USA) with 10 pmol of each primer specific for methylated or unmethylated H19 upstream region 
Statistical analysis
Statistical analysis was performed using Instat 5 (GraphPAD Software for Science, San Diego, USA). Data reported are the mean + SEM and were analysed using the non-parametric Mann-Whitney t-test (Figs 1D and E, 2A, 3A and B) , one-way ANOVA (Fig. 1A and B) . Data expressed as percentages were analysed using the Fisher's exact test (Fig. 4B) and the x 2 test (Fig. 4A) . Only P values ,0.05 were considered significant.
Results
Compromised DNA methylation in developing IVP placentae
We assessed the activity and quantified the expression of DNMT1 in developing sheep placentae and at term (Fig. 1) . The enzymatic activity of DNMT1 was reduced throughout the studied period of placentogenesis (Days 20 -28) in IVP placentae in comparison with controls ( Fig. 1A , P , 0.001). Conversely, the DNMT1 mRNA level in IVP placentae (versus controls) was lower at Days 20 -22 ( Fig. 1D , P , 0.05), and at Days 20-24, for protein expression (Fig. 1B , P , 0.01; Fig. 1C) . Moreover, the significant lower expression of HDAC2, DMAP1 and UHRF1 (DNMT1 co-factors) was also observed in IVP placentae in comparison with controls, but only at Day 20 of pregnancy ( Fig. 1E , P , 0.05). No difference in the mRNA or protein level was observed between IVP and control placentae at term. The expression and methylation status of imprinted genes in growing placentae were also affected by IVP (Fig. 2) .
Reduced embryo growth and survival
We then followed the development of IVP and control sheep embryos between Days 20 and 28. The phase of exponential growth, which in sheep occurs between Days 22 and 24 of pregnancy, was delayed by 48 h in IVP embryos ( Fig. 3A and B) in comparison with controls. Accordingly, they were 60% smaller than controls at Day 24 of development (embryo diameter ¼ 1.2 cm for IVP embryos and 2.1 cm for controls) (P , 0.05). No size difference between IVP and control fetuses was observed at later stages. Frequent, more or less diffused haemorrhages in IVP fetuses and/or placentae were observed at Days 24 and 26 (Fig. 3C) . Furthermore, the number of dead IVP fetuses was significantly higher than that of control fetuses at Days 24 and 26 of development ( Fig. 4A , P , 0.05); however, after the fourth week of gestation, the percentage loss of IVP embryos became stable (Fig. 4B) . Moreover, the developmental stage and general appearance (resorption) of many dead IVP fetuses collected at Days 26 and 28 indicated that they did actually die at Day 24 (Fig. 4A) . These findings together with the temporal kinetic data on the expression of DNMT1 and its cofactors (Fig. 1) indicate that Day 24 of development is critical (developmental bottleneck) for IVP sheep embryos. HDAC2, histone deacetylase 2; UHRF1, ubiquitin-like, containing PHD and RING finger domain 1; PCNA, proliferating cell nuclear antigen; DMAP1, DNA methyltransferase 1 associated protein 1 (E). Results are the mean + SEM. ***P , 0.001, **P , 0.01, *P , 0.05 versus CTR. Number of samples used: IVP n ¼ 12 and CTR n ¼ 12.
Embryo mortality and DNA methylation in sheep placenta
Discussion
Although it is recognized that in vitro embryo production may compromise the methylation of genes, particularly those which are imprinted, the involvement of DNMT1 machinery in early postimplantation development of IVP embryos had not been investigated before. Our results show that DNMT1 dysfunction in placentae of IVP sheep embryos is associated with growth restriction and death around Day 24 of pregnancy. As living IVP embryos collected at subsequent stages were not retarded and normal levels of DNMT1 expression were observed in their placenta, we propose that DNMT1 is involved in key life -death processes at this stage of organogenesis (a developmental bottleneck). Similarly, mouse embryos in which DNA methylation is defective develop only until 8.5 dpc, which corresponds to Day 22 of sheep development (Li et al., 1992; Sakaue et al., 2010) . In order to pass to the next stage, genomic imprinting needs to be correctly established (sheep: Young et al., 2003; Thurston et al., 2008; mouse: Schulz et al., 2010) . At this developmental bottleneck, mouse embryos with compromised genomic imprinting, including Dnmt1 knock-out embryos (Evans and Sack, 1973; Li et al., 1992) , exhibit phenotypic characteristics which are similar to those of the IVP sheep embryos in our study: both are stunted, with extended vascularization defects (haemorrhages) or already dead (Evans and Sack, 1973; Kauffman, 1994) . Previous studies in mice confirmed that defective genomic imprinting causes embryonic loss mainly at 9.5 dpc (Evans and Sack, 1973; Bourc'his et al., 2001; Kaneda et al., 2004; Toppings et al., 2008) . Here, the methylation status of H19 as well as mRNA expression of this and of other maternally and paternally imprinted genes in early placentae (Days 20-22 of pregnancy) was influenced by IVP. Frequent loss of methylation imprint at the H19 locus in cultured mouse embryos occurs only up to 9.5 dpc (Mann et al., 2004) , whereas at 10.5 dpc living embryos have correct genomic imprints and increased number of resorptions is observed, suggesting that embryos with defective imprinting do not survive (Fauque et al., 2010) . The H19 gene has been considered as a sensor of epigenetic disturbances caused by ART (Fauque et al., 2007) . The H19 gene plays a major role in fetal growth, through its effect on nutrient transfer from the mother to the fetus (Fowden et al., 2006) . At the stage of developmental bottleneck, the placental vascular network starts to play a critical role in supporting embryo growth in both sheep (Boshier, 1969; Guillomot et al., 1981; Barry and Anthony, 2008a,b) and mouse (Evans and Sack, 1973) . Frequently observed haemorrhages in IVP sheep conceptuses are indicative of defective endothelial cells, which are the earliest indicator of faulty vascularization. It has been shown that elevated concentrations of homocystein can inhibit endothelial cell growth (Jamaluddin et al., 2007) and reduce DNMT1 activity (Kullo et al., 2006; Jamaluddin et al., 2007) . In our study, DNMT1 activity in early placentae from IVP embryos was constantly suppressed, thus possibly explaining the occurrence of haemorrhages also in living embryos and of the delayed exponential growth of IVP embryos. Although the analysis of homocystein levels was not the object of our study, it may be worth noting that an elevated concentration of this amino acid was identified as a risk factor for early human pregnancy, in particular in pregnancies obtained by ART (Nelen et al., 2000; Jamaluddin et al., 2007; Pacchiarotti et al., 2007) . Elevated levels of homocystein may be the consequence of poor folate status in the cells because homocystein is normally converted to methionine via the folate pathway (Solanky et al., 2009) . Therefore, endothelial function could be rescued by folic acid supplementation during pregnancy (Cheng et al., 2009 ), a promising approach to improve placental vascularization of IVP embryos. The DNMT1 down-regulation observed here together with downregulation of genes which regulate DNMT1 function (such as DMAP1, UHRF1, HDAC2) confirms a failure of the whole machinery involved in the maintenance of methylation marks. DNMT1 down-regulation is not an absolute requirement for genomic hypomethylation in the placental tissue (Novakovic et al., 2010) . Although DNMT1 expression was severely compromised in IVP placentae only up to the developmental bottleneck, some defects (such as low DNMT1 enzymatic activity) were observed also at later stages. This may indicate that only major perturbations in the functionality of the DNMT1 machinery will not allow the embryo to progress through this developmental stage, while other errors may be tolerated, allowing the pregnancy to proceed to term. Our finding implies that adequate functionality of DNMT1 appears to be particularly important during early placentation, while its lower enzymatic activity, which persisted at subsequent stages, is not lethal for IVP embryos. This hypothesis is in line with previous findings in pregnant rats showing that methylation defects affected placental function during earlier stages of pregnancy, while they were without effect on the pregnancy performance at later stages (Serman et al., 2007) . It is likely that DNA methylation is important for the initial specialization of placental cell lineages and not for their further growth. Indeed, DNA methylation has been recently demonstrated to be dispensable for growth and survival of the extraembryonic lineages (Sakaue et al., 2010) .
Generally, a higher frequency of epigenetic errors is observed during early rather that late pregnancy stages both in mice (Khosla et al., 2001; Mann et al., 2004; Fauque et al., 2010) and in humans (Amor and Halliday 2008; Pozharny et al., 2010; Turan et al., 2010) . Indeed, only marginal alterations in gene expression were found in human placentae collected after delivery of healthy ART babies (Zhang et al., 2010) . The lower level of methylation of imprinted genes in full-term placentae of growth-restricted neonates and newborns obtained by ART may thus be attributed to persisting functional defects in the DNMT1 machinery (Katari et al., 2009; Turan et al., 2010; Koukoura et al., 2011) . Such persisting defects may also explain the anomalies in fetal-maternal pre-parturition signalling (Ptak et al., 2002) . In humans, ART pregnancies often require hormonal stimulation of labour or Caesarean section, thus making the study of the fetal-maternal pre-parturition signalling unfeasible. However, in animals, delayed and difficult deliveries and a largely increased risk of stillbirths are often observed during delivery of offspring produced in vitro, which may suggest placental DNMT1 dysfunction (Ptak et al., 1999 (Ptak et al., , 2002 Farin et al., 2006) .
In vitro procedures might alter the establishment of genomic imprinting in the developing embryo. The functional haploid state of imprinted genes might render them particularly vulnerable to environmental effects, such as in vitro culture (Trasler, 2006; Bourc'his and Proudhon, 2008) . Similarly, monoallelic expression of the DNMT1 gene (in the absence of parent-of-origin imprinting) (Novakovic et al., 2010) makes this gene susceptible to environmental disturbances and thus to loss of methylation following in vitro embryo culture, as for imprinted genes. As the correct maintenance of imprints is dependent exclusively on DNMT1 function (Kurihara et al., 2008) , the alteration of imprinting in IVP embryos could be the downstream consequence of a primary dysfunction of this enzyme. In conclusion, our results suggest that the modification of imprinting is not a direct effect of IVP technology, but rather a Figure 3 Post-implantation growth of IVP sheep embryos (A and B, curvilinear and crown-rump, respectively). Growth retardation of IVP embryos in comparison with CTR at Day 24 of development. Note also that the phase of exponential growth of embryos is delayed by 48 h in IVP embryos. (C) CTR and IVP fetuses from Days 20 to 28. Fetuses were considered dead when a beating heart was not observed. Note extensive haemorrhages (white arrow) and small haemorrhagic petechiae (black arrows) in fetuses and placentae. Asterisk denotes fetal resorption at Day 28. For each day of development five or more embryos were collected. Results are the mean + SEM. *P , 0.05 (IVP day 24 versus CTR day 24), a: P , 0.05 (CTR day 22 versus CTR day 24), b: P , 0.05 (IVP day 24 versus IVP day 26).
Embryo mortality and DNA methylation in sheep placenta consequence of deregulation of the DNMT1 machinery. The novelty of our finding consists of identifying down-regulation of DNMT1 as an upstream cause of the previously reported deregulation of gene methylation and expression following in vitro culture (Fauque et al., 2007 (Fauque et al., , 2010 Katari et al., 2009) . However, this observation does not exclude the role of other factors that affect the transcriptome and development of embryos conceived in vitro. As our study is the only one evaluating the functionality of DNMT1 machinery following ART, more studies are needed to confirm if IVP causes DNMT1 deregulation in other species and experimental settings. The knowledge about compromised activity of DNMT1 in placentae obtained from IVP embryos should stimulate the development of strategies to overcome this problem. Such strategies should include detailed studies on the metabolic requirements of oocytes and embryos in order to adequately enrich the culture media, and then the development of adequate dietary/pharmacological treatments for females undergoing assisted conception. 
